Gene Expression Profiling of Progressive Papillary Noninvasive Carcinomas of the Urinary Bladder
- 15 June 2005
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 11 (12) , 4415-4429
Abstract
Purpose: The aim of the present study was to define gene expression profiles of noninvasive and invasive bladder cancer, to identify potential therapeutic or screening targets in bladder cancer, and to define genetic changes relevant for tumor progression of recurrent papillary bladder cancer (pTa). Experimental Design: Overall, 67 bladder neoplasms (46 pTa, 3 pTis, 10 pT1, and 8 pT2) and eight normal bladder specimens were investigated by a combination of laser microdissection and gene expression profiling. Eight of 16 patients with recurrent noninvasive papillary bladder tumors developed carcinoma in situ (pTis) or invasive bladder cancer (≥pT1G2) in the course of time. RNA expression results of the putative progression marker cathepsin E (CTSE) were confirmed by immunohistochemistry using high-throughput tissue microarray analysis (n = 776). Univariate analysis of factors regarding overall survival, progression-free survival, and recurrence-free survival in patients with urothelial bladder cancer was done. Results: Hierarchical cluster analyses revealed no differences between pTaG1 and pTaG2 tumors. However, distinct groups of invasive cancers with different gene expression profiles in papillary and solid tumors were found. Progression-associated gene profiles could be defined (e.g., FABP4 and CTSE) and were already present in the preceding noninvasive papillary tumors. CTSE expression (P = 0.003) and a high Ki-67 labeling index of at least 5% (P = 0.01) were the only factors that correlated significantly with progression-free survival of pTa tumors in our gene expression approach. Conclusions: Gene expression profiling revealed novel genes with potential clinical utility to select patients that are more likely to develop aggressive disease.Keywords
All Related Versions
This publication has 43 references indexed in Scilit:
- Identifying Superficial, Muscle-Invasive, and Metastasizing Transitional Cell Carcinoma of the BladderClinical Cancer Research, 2004
- Molecular analysis of transitional cell carcinoma using cDNA microarrayOncogene, 2003
- HER‐2 and TOP2A coamplification in urinary bladder cancerInternational Journal of Cancer, 2003
- Molecular Grading of Urothelial Cell Carcinoma With Fibroblast Growth Factor Receptor 3 and MIB-1 is Superior to Pathologic Grade for the Prediction of Clinical OutcomeJournal of Clinical Oncology, 2003
- Expression of peroxisome proliferator‐activated receptors (PPARs) in human urinary bladder carcinoma and growth inhibition by its agonistsInternational Journal of Cancer, 2003
- Selective Cooperation between Fatty Acid Binding Proteins and Peroxisome Proliferator-Activated Receptors in Regulating TranscriptionMolecular and Cellular Biology, 2002
- New Functional Aspects of Cathepsin D and Cathepsin EMolecules and Cells, 2000
- Clinical significance of cathepsin E in pancreatic juice in the diagnosis of pancreatic ductal adenocarcinomaJournal of Gastroenterology and Hepatology, 2000
- Distinct types of diffuse large B-cell lymphoma identified by gene expression profilingNature, 2000
- Biology and Management of Bladder CancerNew England Journal of Medicine, 1990